A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment

OBJECTIVE: To determine whether dapagliflozin, which selectively inhibits renal glucose reabsorption, lowers hyperglycemia in patients with type 2 diabetes that is poorly controlled with high insulin doses plus oral antidiabetic agents (OADs). RESEARCH DESIGN AND METHODS: This was a randomized, doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilding, John P.H., Norwood, Paul, T'joen, Caroline, Bastien, Arnaud, List, James F., Fiedorek, Fred T.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732143/
https://www.ncbi.nlm.nih.gov/pubmed/19528367
http://dx.doi.org/10.2337/dc09-0517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732143/
https://www.ncbi.nlm.nih.gov/pubmed/19528367
http://dx.doi.org/10.2337/dc09-0517

Ejemplares similares